Table 3.
Breast surgery | CS 7.8% | CS/RT 61.7% | MX 30.5% |
(France) | Range (84–96%) | Range (20–37%) | |
(United States) | Range (39–74%) | Range (26–45%) | |
| |||
Axillary surgery | SLNB 21.3% | AD 10.4% | |
| |||
Hormonal therapy | HT 13.4% | ||
(France) range (6–34%) |
Reference [29].